| |
|
|
|
|
|
Sandoz and Aequus Agree to 1-Year Extension on Vistitan in Canada
|
|
Vancouver, BC, January 20, 2022--Aequus Pharmaceuticals Inc. (TSX-V: AQS,OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced a 1-year extension of terms with Sandoz Canada Inc., with option for parties to renew, for promotional services related to Vistitan (bimatoprost 0.03% ophthalmic solution).
|
|
|
|
|
|
|
|
|
|
|
|
Aequus Provides Third Quarter 2020 Financial Highlights
|
|
Vancouver, BC, December 15, 2020--Aequus Pharmaceuticals Inc. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, reported financial results for the three months ended September 30, 2020 and associated Company developments.
|
|
|
|
|
|
|
|
Aequus Announces Leadership Change, Anne Stevens Stepping Down as Chief Operating Officer
|
|
Vancouver, BC, December 9, 2020--Aequus Pharmaceuticals Inc. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products announced that Ms Anne Stevens is stepping down from her role as Chief Operating Officer. Ms Stevens will remain a Director and will continue to serve on the Aequus Board of Directors.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aequus Provides General Update and Second Quarter 2020 Financial Highlights
|
|
Vancouver, BC, September 9, 2020--Aequus Pharmaceuticals Inc. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, reported financial results for the three months ended June 30, 2020 and six months ended June 30, 2020 and associated Company developments.
|
|
|
|
|
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
Employers
Post Job Listings
Advertise
